Navigation Links
Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
Date:9/4/2007

t many patients do not respond, and if they do respond, they typically relapse within a short time after treatment. There is currently no FDA-approved therapy and no consistent and effective therapy for SCLC patients who have platinum-resistant or -refractory disease after treatment failure with first-line combination therapy with either cisplatin or carboplatin. No new drugs have been approved by the FDA for the treatment of platinum-resistant or -refractory SCLC in nearly a decade.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative oncology products to impact the lives of people with cancer. Picoplatin, the Company's lead product candidate, is a new generation platinum therapy with an improved safety profile. Picoplatin is designed to overcome and prevent platinum resistance associated with chemotherapy in solid tumors. Intravenous picoplatin is currently being studied in clinical trials for the treatment of small cell lung, colorectal and hormone-refractory prostate cancer, and oral picoplatin is in a clinical trial in solid tumors. As part of the Company's strategic goal of building a diverse oncology pipeline, the Company is collaborating with The Scripps Research Institute on the discovery of novel, small-molecule, multi-targeted protein kinase inhibitors. For additional information please visit http://www.poniard.com.

This release contains forward-looking statements, including statements regarding the Company's business objectives and strategic goals, drug development plans, results of clinical trials and the potential safety and efficacy of its products in development. The Company's actual results may differ materially from those indicated in these forward-looking statements based on a number of factors, including risks and uncertainties associated with the Company's research an
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
2. Poniard Pharmaceuticals Announces Clinical Data from Picoplatin Phase 2 Small Cell Lung Cancer Trial To Be Presented at American Society of Clinical Oncology Annual Meeting
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015 DePuy ... agreement with Radlink, Inc., an emerging global leader ... image guidance with its hip replacement systems. The ... to help improve patient outcomes, increase patient satisfaction ... with the 81st annual meeting of the American ...
(Date:3/26/2015)... CAMBRIDGE, Mass. , March 26, 2015 ... today announced that it will present preclinical ... pipeline at the 2015 American Association for ... April 18-22, 2015 at the Pennsylvania Convention Center in Philadelphia. The ... antibody engineering and nanoliposomal technology platforms, as ...
(Date:3/26/2015)... SANTA CLARA , Kalifornien, 26. März ... neue Veranstaltung Cellworld 2015, die sich speziell ... Bioprozesstechnologien richtet, an. Die zweitägige ... bis 22. September 2015 im Hyatt Regency ... statt. In diesem Forum werden führende ...
Breaking Medicine Technology:DePuy Synthes Companies Announces Exclusive Agreement With Radlink To Help Address Key Challenges In Hip Replacement 2DePuy Synthes Companies Announces Exclusive Agreement With Radlink To Help Address Key Challenges In Hip Replacement 3Merrimack to Highlight Extensive Oncology Pipeline at the 2015 American Association for Cancer Research Annual Meeting 2Merrimack to Highlight Extensive Oncology Pipeline at the 2015 American Association for Cancer Research Annual Meeting 3Finesse Solutions kündigt Cellworld 2015 an 2
(Date:3/26/2015)... 2015 Building off their success ... education, the Cardiometabolic Risk Summit and ... University are proud to announce a pioneering ... interdisciplinary program , which ultimately grants a ... for physicians, nurse practitioners, physician assistants, registered dietitians, ...
(Date:3/26/2015)... CO (PRWEB) March 26, 2015 Saving ... help where it is most needed but least available. ... therapeutic milk to six clinics in the Benguela province ... severe malnutrition. During a recent visit to their clinics, ... to the mothers and their babies in a nation ...
(Date:3/26/2015)... Capistrano, Calif. (PRWEB) March 26, 2015 ... and repairs, is pleased to be featured on Innovations ... Channel on March 18, 2015. The episode will ... it is live on the Pacific Medical home page ... face life threatening emergencies, it is reassuring to trust ...
(Date:3/26/2015)... Washington DC (PRWEB) March 26, 2015 ... Center for Assessment and Evaluation , has ... technologies that enable institutions, organizations, and corporations to ... to promote successful learning. , Utilizing Questionmark’s ... Testing Services will offer improved delivery of ...
(Date:3/26/2015)... Topsfield, MA (PRWEB) March 26, 2015 ... faced by Skilled Nursing and Assisted Living facilities ... and policy changes during the year. The ... Rehabilitation Therapists, MDS coordinators, CNA’s and the ... the Harmony Healthcare International website ( http://www.harmony-healthcare.com ) ...
Breaking Medicine News(10 mins):Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 2Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 3Health News:Saving Moses Utilized Photography in an Effort to Engage Mothers and Their Babies on a Recent Visit to Angola 2Health News:Pacific Medical Featured on the Discovery Channel 2Health News:Pacific Medical Featured on the Discovery Channel 3Health News:NLN Testing Services Announces Improved Delivery and Analytics Software and Newly Developed and Revised Exams 2Health News:Harmony Healthcare International Releases 2015 Post Acute Care Trends Report 2Health News:Harmony Healthcare International Releases 2015 Post Acute Care Trends Report 3
... money to pay for badly needed restorations, are reaching out ... parades, bird-watching lectures, Sunday jazz concerts, brunches with star ... calendar. ,The cemetery tourism fever is catching on. ... aboard the Titanic made many gasp for breath. It looked ...
... of Chaucer were not dwarfs but only short by two ... case with women more or less, a new study by ... ,As part of their study, scientists researched 3000 skeletons ... North East Lincolnshire, and found that the average height of ...
... has found that smokers who have a say in how ... and are more successful. ,The study, which ... of human motivation, was conducted by a team of researchers ... ,The crux of Self-Determination Theory is that a ...
... is of the view that glycerin, a by-product of bio-diesel, ... , ,In his study, Monty Kerley, a professor of ... effectiveness of glycerin as cattle feed. ,Through ... from various breeds to determine if bio-leftovers provide a healthy ...
... four doctors engaged in the illegally removing human kidneys, ... night after police apprehended three middlemen and recovered nine men ... in the city, Lahore police chief Aftab Cheema said. ... raided two private hospitals where the four people underwent surgery. ...
... nation's doctors to work for rural patients. ... in Rohtak, Kalam called upon doctors to make medical facilities ... the zeal to treat at least 20 rural patients a ... taken care of. ,Kalam also told doctors ...
Cached Medicine News:Health News:Cemetery Tourism, the New Catchword in US 2Health News:Our Medieval Ancestors Were More or Less Similar to Us Than Previously Thought 2Health News:Smokers Who Have a Say in How They Quit More Likely to Kick the Habit 2Health News:Study Finds Glycerin to Be a Good Source for Cattle Feed 2
Plus cylinders only trial lens set....
Magnets move the color disks, Protects Disks from fingerprints, Keeps all the disks in one place, Clear glass insures accurate color perception, Makes Color testing fun....
Opti-Free Express multi-purpose disinfecting solution lasting comfort No Rub formula provides triple action protection for your contact lenses....
Grafton Trial Frame...
Medicine Products: